GamReg Sweden - Quality Register for Gambling and Gaming Disorders

March 2, 2022 updated by: Region Skane

This is a quality register for the monitoring of clinical assessment and treatment for gambling disorder and gaming disorder in Swedish health care.

This register is held by Region Skåne, the health care organization of Skåne in southern Sweden, and administered by Register center South, which is associated with health care services in the southern regions of Sweden (the establishment of quality registers in Swedish health care relies upon a national legislation). Quality registers by themselves do not represent formal research projects. However, future research projects can use quality registers, such as the present one, as a data source for future research projects in case they are approved by an ethics authority.

Clinical study variables collected in the register include the following (examples):

  • gender, age, occupation, living conditions
  • if applicable, types of gambling associated with the treatment needs
  • if applicable, type of problematic video gaming
  • type of referral to the present treatment contact
  • treatment history in psychiatry, social services, enforcement agency
  • history of suicidal behavior
  • alcohol and drugs problems requiring assessment or treatment
  • violence victimization
  • type of treatment provided to the patient

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Sweden
      • Malmö, Sweden
        • Recruiting
        • Malmö Addiction Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All included subjects.

Description

Inclusion Criteria:

  • All patients assessed and treated at units where treatment of problem gambling or problem gaming is provided

Exclusion Criteria:

  • Patients who - in a standardized opt-out procedure (following standard of national regulation for quality registers) - refuse participation in the quality register

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment uptake
Time Frame: 1 year
Number of patients treated (assessed annually)
1 year
Characteristics of treatment-seeking patients
Time Frame: 1 year
Characteristics of treatment-seeking patients (socio-demographic and mental health co-morbidities), assessed annually
1 year
Distribution of treatment methods provided (assessed annually)
Time Frame: 1 year
Distribution of treatment methods provided (cognitive-behavioral therapy, motivational interviewing, psycho-dynamic treatment, medication, etc, assessed annually)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Region Skane

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2019

Primary Completion (Anticipated)

December 31, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

February 11, 2022

First Submitted That Met QC Criteria

March 2, 2022

First Posted (Actual)

March 11, 2022

Study Record Updates

Last Update Posted (Actual)

March 11, 2022

Last Update Submitted That Met QC Criteria

March 2, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GamReg Sweden

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe